Wook Kim
Direttore Finanziario/CFO presso HLB GLOBAL CO., LTD.
Posizioni attive di Wook Kim
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HLB CO., LTD. | Direttore/Membro del Consiglio | - | - |
| HLB GLOBAL CO., LTD. | Direttore/Membro del Consiglio | 01/08/2018 | - |
| Direttore Finanziario/CFO | 01/08/2018 | - |
Storia della carriera di Wook Kim
Precedenti posizioni note di Wook Kim
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Direttore/Membro del Consiglio | 01/01/2019 | - |
Formazione di Wook Kim
| Korea University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Corea del Sud | 4 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 3 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Energy Minerals | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HLB CO., LTD. | Health Technology |
| HLB GLOBAL CO., LTD. | Energy Minerals |
| Aziende private | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Wook Kim
- Esperienza
